Results from research on dehydroepiandrosterone backed by Fertility Nutraceuticals LLC will be used to support an application for a patent for a qualified health claim that DHEA supplementation benefits pre-menopausal women's sexual function.
"We've identified the patient population that would benefit from this," said Vitaly Kushnir, director of the Fertility Preservation Center at the Center for Human Reproduction in New York,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?